
Is MEDP (Medpace Holdings, Inc.) Halal or Haram?
Medpace Holdings comfortably passes all AAOIFI Shariah screening criteria, making it a Halal investment option. The company operates with exceptionally low leverage, maintaining a debt-to-market cap ratio of just 2.1%, well below the 33% threshold. Furthermore, its interest income is non-existent at 0.00%, highlighting a remarkably clean balance sheet free from impermissible financial activities.
Price Chart (5D)
MEDP — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-06-08 | 454.25 | 462.09 | 450.06 | 457.90 | 187K | +0.80% |
| 2026-06-05 | 453.53 | 458.00 | 442.95 | 454.25 | 191K | +0.16% |
| 2026-06-04 | 454.24 | 466.22 | 454.14 | 458.69 | 221K | +0.98% |
| 2026-06-03 | 445.40 | 451.68 | 434.38 | 450.82 | 240K | +1.22% |
| 2026-06-02 | 445.35 | 449.38 | 438.04 | 445.59 | 299K | +0.05% |
| 2026-06-01 | 446.43 | 460.90 | 444.41 | 451.47 | 251K | +1.13% |
| 2026-05-29 | 446.72 | 453.54 | 441.92 | 447.11 | 289K | +0.09% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for MEDP
Business Activity
Permissible
Medpace Holdings passes the business activity screen as its core operations in clinical research and drug development services for the pharmaceutical and biotechnology industries are entirely permissible under Islamic principles.
Debt / Market Cap
2.11%
Interest Income
0.00%
Cash & Securities
4.20%
About Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP) is a globally recognized clinical contract research organization (CRO) that accelerates the development of medical devices and drugs. The company provides comprehensive Phase I to Phase IV clinical trial services, supporting the biotechnology, pharmaceutical, and medical device industries across North America, Europe, and Asia.
For Muslim investors, Medpace represents a strong Halal investment opportunity within the healthcare sector. The stock successfully passes all four AAOIFI Shariah screens, meaning both its core business activities in medical research and its financial structures align with Islamic financial principles.
From an Islamic finance perspective, Medpace boasts an exceptionally clean balance sheet. The company carries negligible interest-bearing debt, with a debt-to-market cap ratio of just 2.1%, and generates absolutely zero interest income, ensuring investors are not exposed to riba-based earnings.
Since there is no significant scholarly debate regarding the permissibility of clinical research, investors can feel confident in this stock's compliance. However, Muslim shareholders should continue to monitor the company's cash reserves and future acquisitions to ensure its financial ratios remain within AAOIFI thresholds.
CEO
August James Troendle
Employees
5,900
IPO Date
2016-08-11
Headquarters
Cincinnati, OH, US
Website
www.medpace.comMEDP Key Financial Statistics
Revenue
$2.53B
Net Income
$451.1M
EPS (Diluted)
$15.28
Stock Price
414.88
Beta
1.39
52-Week Range
284.1-628.916
Total Debt
$250.5M
Total Equity
$459.1M
Current Ratio
0.74
MEDP Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+20.0%
Prior year: $2.11B
Net Cash
$246.6M
Cash: $497.0M — Debt: $250.5M
Frequently Asked Questions About MEDP
Is MEDP (Medpace Holdings, Inc.) stock halal to invest in?▾
What does Medpace Holdings, Inc. do?▾
What screening criteria were used for MEDP?▾
Does MEDP require income purification?▾
When was MEDP last screened?▾
Disclaimer
This shariah compliance assessment for MEDP (Medpace Holdings, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-27.